ATE273711T1 - Verwendung von niedermolekularem heparin zur behandlung und/oder prophylaxe motoneuronaler krankheiten - Google Patents
Verwendung von niedermolekularem heparin zur behandlung und/oder prophylaxe motoneuronaler krankheitenInfo
- Publication number
- ATE273711T1 ATE273711T1 AT99958308T AT99958308T ATE273711T1 AT E273711 T1 ATE273711 T1 AT E273711T1 AT 99958308 T AT99958308 T AT 99958308T AT 99958308 T AT99958308 T AT 99958308T AT E273711 T1 ATE273711 T1 AT E273711T1
- Authority
- AT
- Austria
- Prior art keywords
- low molecular
- prophylaxis
- treatment
- molecular heparin
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9815919A FR2787329B1 (fr) | 1998-12-17 | 1998-12-17 | Nouvelle application therapeutique des heparines de bas poids moleculaire |
| PCT/FR1999/003109 WO2000035462A1 (fr) | 1998-12-17 | 1999-12-13 | Nouvelle application therapeutique des heparines de bas poids moleculaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE273711T1 true ATE273711T1 (de) | 2004-09-15 |
Family
ID=9534065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99958308T ATE273711T1 (de) | 1998-12-17 | 1999-12-13 | Verwendung von niedermolekularem heparin zur behandlung und/oder prophylaxe motoneuronaler krankheiten |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US20020040013A1 (de) |
| EP (1) | EP1140119B1 (de) |
| JP (1) | JP2002532431A (de) |
| AT (1) | ATE273711T1 (de) |
| AU (1) | AU1569700A (de) |
| CA (1) | CA2354762C (de) |
| DE (1) | DE69919578T2 (de) |
| DK (1) | DK1140119T3 (de) |
| ES (1) | ES2222748T3 (de) |
| FR (1) | FR2787329B1 (de) |
| IL (2) | IL143279A0 (de) |
| NO (1) | NO20012849L (de) |
| PT (1) | PT1140119E (de) |
| SI (1) | SI1140119T1 (de) |
| WO (1) | WO2000035462A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4897991B2 (ja) * | 1999-07-23 | 2012-03-14 | ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ | 超低分子量ヘパリン組成物 |
| US7511026B2 (en) | 2003-03-25 | 2009-03-31 | Seikagaku Corporation | Therapeutic agent for nerve damage |
| BRPI0408889A (pt) * | 2003-03-28 | 2006-04-11 | Applied Research Systems | uso de clusterina para o tratamento e/ou prevenção de doenças neurológicas periféricas |
| FR3000746A1 (fr) | 2013-01-04 | 2014-07-11 | Centre Nat Rech Scient | Peptide pour son utilisation dans le traitement des neuronopathies motrices |
| RU2639574C2 (ru) * | 2016-05-23 | 2017-12-21 | Алексей Георгиевич Александров | Способ получения низкомолекулярного гепарина |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4608365A (en) * | 1984-03-30 | 1986-08-26 | University Of Southern California | Treatment of neurologic functions |
| JPH04507234A (ja) * | 1988-04-22 | 1992-12-17 | ベイラー・カレッジ・オブ・メディスン | 筋萎縮性側索硬化症の治療用組成物の製造方法 |
| AU6872691A (en) * | 1989-10-27 | 1991-05-31 | Case Western Reserve University | Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans |
| US6258341B1 (en) * | 1995-04-14 | 2001-07-10 | Inhale Therapeutic Systems, Inc. | Stable glassy state powder formulations |
| FR2740686B1 (fr) * | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
| US6491965B1 (en) * | 1995-11-30 | 2002-12-10 | Hamilton Civic Hospitals Research Development, Inc. | Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
| FR2763849B1 (fr) * | 1997-05-28 | 2000-09-15 | Rhone Poulenc Rorer Sa | Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux |
| US6608042B2 (en) * | 2000-03-28 | 2003-08-19 | Aventis Pharma, S.A. | Pharmaceutical compositions containing oligosaccharides, the novel oligosaccharides and preparation thereof |
-
1998
- 1998-12-17 FR FR9815919A patent/FR2787329B1/fr not_active Expired - Lifetime
-
1999
- 1999-12-13 SI SI9930631T patent/SI1140119T1/xx unknown
- 1999-12-13 AT AT99958308T patent/ATE273711T1/de not_active IP Right Cessation
- 1999-12-13 WO PCT/FR1999/003109 patent/WO2000035462A1/fr active IP Right Grant
- 1999-12-13 EP EP99958308A patent/EP1140119B1/de not_active Expired - Lifetime
- 1999-12-13 JP JP2000587782A patent/JP2002532431A/ja active Pending
- 1999-12-13 PT PT99958308T patent/PT1140119E/pt unknown
- 1999-12-13 CA CA2354762A patent/CA2354762C/fr not_active Expired - Fee Related
- 1999-12-13 DK DK99958308T patent/DK1140119T3/da active
- 1999-12-13 DE DE69919578T patent/DE69919578T2/de not_active Expired - Lifetime
- 1999-12-13 ES ES99958308T patent/ES2222748T3/es not_active Expired - Lifetime
- 1999-12-13 AU AU15697/00A patent/AU1569700A/en not_active Abandoned
- 1999-12-13 IL IL14327999A patent/IL143279A0/xx active IP Right Grant
-
2001
- 2001-05-21 IL IL143279A patent/IL143279A/en not_active IP Right Cessation
- 2001-06-08 NO NO20012849A patent/NO20012849L/no not_active Application Discontinuation
- 2001-06-14 US US09/881,267 patent/US20020040013A1/en not_active Abandoned
-
2003
- 2003-08-20 US US10/644,150 patent/US20040038938A1/en not_active Abandoned
- 2003-08-20 US US10/644,109 patent/US20030236222A1/en not_active Abandoned
-
2005
- 2005-12-21 US US11/314,130 patent/US20060100175A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20020040013A1 (en) | 2002-04-04 |
| EP1140119B1 (de) | 2004-08-18 |
| EP1140119A1 (de) | 2001-10-10 |
| DK1140119T3 (da) | 2004-12-20 |
| IL143279A (en) | 2006-12-10 |
| NO20012849D0 (no) | 2001-06-08 |
| JP2002532431A (ja) | 2002-10-02 |
| PT1140119E (pt) | 2004-11-30 |
| IL143279A0 (en) | 2002-04-21 |
| AU1569700A (en) | 2000-07-03 |
| US20030236222A1 (en) | 2003-12-25 |
| SI1140119T1 (en) | 2004-10-31 |
| DE69919578T2 (de) | 2005-07-14 |
| FR2787329A1 (fr) | 2000-06-23 |
| NO20012849L (no) | 2001-06-08 |
| WO2000035462A1 (fr) | 2000-06-22 |
| US20040038938A1 (en) | 2004-02-26 |
| ES2222748T3 (es) | 2005-02-01 |
| CA2354762C (fr) | 2010-02-09 |
| DE69919578D1 (de) | 2004-09-23 |
| US20060100175A1 (en) | 2006-05-11 |
| CA2354762A1 (fr) | 2000-06-22 |
| FR2787329B1 (fr) | 2001-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69733329D1 (de) | Verwendung von Taurin zur Behandlung oder Vorbeugung von ischämischen Verletzungen | |
| ATE555803T1 (de) | Verwendung von osteopontin zur behandlung und/oder vorbeugung von neurologischen erkrankungen | |
| DE60114580D1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
| UY26249A1 (es) | Moléculas pequenas útiles en el tratamiento de las enfermedades inflamatorias ley 17164 art. 127 | |
| DE69921156D1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
| DE69532804D1 (de) | Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis | |
| ATE362374T1 (de) | Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust | |
| ATE235495T1 (de) | 8-arylalkyl- und 8-arylheteroalkyl-5, 11-dihydro- 6h-dipyrido-(3,2-b:2', 3'-e)(1,4)diazepine und ihre verwendung zur vorbeugung oder behandlung von hiv-infektion | |
| DE69638281D1 (de) | Anti-Interleukin-9 Antikörper oder Anti-Interleukin-9 Rezeptor Antikörper zur Behandlung von bronchialem Hyperreaktionsvermögen | |
| DE59707519D1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen | |
| ATE273711T1 (de) | Verwendung von niedermolekularem heparin zur behandlung und/oder prophylaxe motoneuronaler krankheiten | |
| DE69910425D1 (de) | Neue therapeutische verwendung von nicergoline | |
| ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| DE69701458D1 (de) | Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen | |
| DE69827387D1 (de) | Verwendung von pramipexol zur behandlung von restless-legs-syndrom | |
| DE69936779D1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen | |
| ATE225181T1 (de) | Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen | |
| ATE275949T1 (de) | Verwendung von diminazen-di-aceturat und/oder pentamidin zur behandlung von malaria | |
| DE69810724D1 (de) | Verwendung von Protein C Inhibitor zur Behandlung disseminierter intravasaler Gerinnung (DIC) | |
| ATA96097A (de) | Verwendung von queller zur behandlung oder prophylaxe von jodmangelerscheinungen | |
| DE69910608D1 (de) | Neue therapeutische verwendung von 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin | |
| ATE209910T1 (de) | Verwendung von 6,7-substituierter 2- aminotetraline zur behandlung von zytokin- vermittleten entzündungszuständen | |
| DE50012015D1 (de) | Mittel zur prävention und/oder behandlung einer gewebeveränderung mesenchymalen ursprungs | |
| DE69822628D1 (de) | Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo[2.1.5-cd]indolizin-derivate | |
| DE59609836D1 (de) | Verwendung von zuckertensiden zur behandlung von ledern und pelzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1140119 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |